These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26839336)

  • 1. The Case for a Pre-Cancer Genome Atlas (PCGA).
    Campbell JD; Mazzilli SA; Reid ME; Dhillon SS; Platero S; Beane J; Spira AE
    Cancer Prev Res (Phila); 2016 Feb; 9(2):119-24. PubMed ID: 26839336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
    Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
    Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic approaches to accelerate cancer interception.
    Beane J; Campbell JD; Lel J; Vick J; Spira A
    Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Events in the Molecular Pathogenesis of Lung Cancer.
    Kadara H; Scheet P; Wistuba II; Spira AE
    Cancer Prev Res (Phila); 2016 Jul; 9(7):518-27. PubMed ID: 27006378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precancer Atlas to Drive Precision Prevention Trials.
    Spira A; Yurgelun MB; Alexandrov L; Rao A; Bejar R; Polyak K; Giannakis M; Shilatifard A; Finn OJ; Dhodapkar M; Kay NE; Braggio E; Vilar E; Mazzilli SA; Rebbeck TR; Garber JE; Velculescu VE; Disis ML; Wallace DC; Lippman SM
    Cancer Res; 2017 Apr; 77(7):1510-1541. PubMed ID: 28373404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic complexity: a call to action.
    Hait WN; Levine AJ
    Sci Transl Med; 2014 Sep; 6(255):255cm10. PubMed ID: 25253671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.
    Lee H; Palm J; Grimes SM; Ji HP
    Genome Med; 2015 Oct; 7():112. PubMed ID: 26507825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
    Zhu Z; Ihle NT; Rejto PA; Zarrinkar PP
    BMC Genomics; 2016 Jun; 17():455. PubMed ID: 27296290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection: the impact of genomics.
    van Lanschot MCJ; Bosch LJW; de Wit M; Carvalho B; Meijer GA
    Virchows Arch; 2017 Aug; 471(2):165-173. PubMed ID: 28573511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.
    Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M
    Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hallmarks of premalignant conditions: a molecular basis for cancer prevention.
    Ryan BM; Faupel-Badger JM
    Semin Oncol; 2016 Feb; 43(1):22-35. PubMed ID: 26970122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.
    Namba R; Maglione JE; Young LJ; Borowsky AD; Cardiff RD; MacLeod CL; Gregg JP
    Mol Cancer Res; 2004 Aug; 2(8):453-63. PubMed ID: 15328372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing.
    Wood HM; Conway C; Daly C; Chalkley R; Berri S; Senguven B; Stead L; Ross L; Egan P; Chengot P; Graham J; Sethi N; Ong TK; High A; MacLennan K; Rabbitts P
    J Pathol; 2015 Nov; 237(3):296-306. PubMed ID: 26096211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
    Rozenblatt-Rosen O; Regev A; Oberdoerffer P; Nawy T; Hupalowska A; Rood JE; Ashenberg O; Cerami E; Coffey RJ; Demir E; Ding L; Esplin ED; Ford JM; Goecks J; Ghosh S; Gray JW; Guinney J; Hanlon SE; Hughes SK; Hwang ES; Iacobuzio-Donahue CA; Jané-Valbuena J; Johnson BE; Lau KS; Lively T; Mazzilli SA; Pe'er D; Santagata S; Shalek AK; Schapiro D; Snyder MP; Sorger PK; Spira AE; Srivastava S; Tan K; West RB; Williams EH;
    Cell; 2020 Apr; 181(2):236-249. PubMed ID: 32302568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.
    Reid BJ
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):359-366. PubMed ID: 28462378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging premalignant biology for immune-based cancer prevention.
    Spira A; Disis ML; Schiller JT; Vilar E; Rebbeck TR; Bejar R; Ideker T; Arts J; Yurgelun MB; Mesirov JP; Rao A; Garber J; Jaffee EM; Lippman SM
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):10750-8. PubMed ID: 27638202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics/epigenetics of oral premalignancy: current status and future research.
    Lingen MW; Pinto A; Mendes RA; Franchini R; Czerninski R; Tilakaratne WM; Partridge M; Peterson DE; Woo SB
    Oral Dis; 2011 Apr; 17 Suppl 1():7-22. PubMed ID: 21382136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On?
    Sinjab A; Han G; Wang L; Kadara H
    Cancer Res; 2020 Nov; 80(22):4888-4891. PubMed ID: 33023945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.